BlueCrest Capital Management’s Amdocs DOX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
– Sell
-4,427
Closed -$240K – 585
2019
Q1
$240K Buy
4,427
+58
+1% +$3.26K 0.01% 835
2018
Q4
$256K Buy
+4,369
New +$274K 0.01% 574
2018
Q2
– Sell
-4,173
Closed -$278K – 1556
2018
Q1
$278K Buy
+4,173
New +$281K 0.01% 1106
2017
Q1
– Sell
-28,202
Closed -$1.64M – 788
2016
Q4
$1.64M Buy
+28,202
New +$1.66M 0.09% 286
2016
Q3
– Sell
-11,360
Closed -$656K – 800
2016
Q2
$656K Buy
11,360
+2,860
+34% +$164K 0.03% 453
2016
Q1
$514K Buy
+8,500
New +$476K 0.03% 497

Other funds holding DOX

BlueCrest Capital Management's DOX Position: Q2 2019 in Review

BlueCrest Capital Management sold out of Amdocs (DOX) in Q2 2019, closing a stake of 4,427 shares — an estimated $240K sold.

BlueCrest Capital Management first reported a position in DOX in Q1 2016 and held it in 6 quarters. The position peaked at $1.64M in Q4 2016. 369 funds tracked by Wall St. Rank hold DOX as of Q2 2019.

  • BlueCrest Capital Management reported no remaining Amdocs position as of Q2 2019 after selling out during the quarter.
  • BlueCrest Capital Management sold 4,427 Amdocs shares in Q2 2019, an estimated $240K.
  • BlueCrest Capital Management first reported a position in Amdocs in Q1 2016 and held it in 6 quarters.
  • BlueCrest Capital Management's Amdocs position peaked at $1.64M in Q4 2016.
  • 369 funds tracked by Wall St. Rank held Amdocs as of Q2 2019.

Based on BlueCrest Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.